Benjamin M. Beckermann

Author

Heidelberg University

Also Known As

B M Beckermann, Benjamin Beckermann, Benjamin M Beckermann, Benjamin M. Beckermann

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Heidelberg University German Cancer Research Center Roche (Switzerland)Assistance Publique – Hôpitaux de Paris University of the Witwatersrand

About

Benjamin M. Beckermann is an author at Heidelberg University specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	266
2	Cell Biology	3	3	190
3	Immunology	2	2	99
4	Allergy	1	1	76
5	Cellular Therapies	1	1	56

Benjamin M. Beckermann

Publications

Citations

H-Index

Page 1

	Year	Citations
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma Benjamin M. Beckermann, Georgios Kallifatidis, Anja Groth, British Journal of Cancer	2008	397
Sulforaphane targets pancreatic tumour-initiating cells by NF-κB-induced antiapoptotic signalling Georgios Kallifatidis, Vanessa Rausch, Bernd Baumann, Gut	2008	229
Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma Chengwen Zhang, Benjamin M. Beckermann, Georgios Kallifatidis, International Journal of Oncology Neuro-oncologyChemotherapy ResistanceGliomaMedicinePharmacology	2006	91
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study Claude Négrier, Johnny Mahlangu, Michaela Lehle, The Lancet Haematology AllergyAutoimmune DiseaseMild Haemophilia AHaven 6Clinical Epidemiology	2023	76
MIRROS: A Randomized, Placebo-Controlled, Phase III Trial of Cytarabine ± Idasanutlin in Relapsed or Refractory Acute Myeloid Leukemia Pau Montesinos, Benjamin M. Beckermann, Olivier Catalani, Future Oncology	2020	72
Idasanutlin Plus Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia: Results of the MIRROS Trial Marina Konopleva, Christoph Röllig, Jamie Cavenagh, Blood Advances	2022	68
Improved lentiviral transduction of human mesenchymal stem cells for therapeutic intervention in pancreatic cancer Georgios Kallifatidis, Benjamin M. Beckermann, Anja Groth, Cancer Gene Therapy Regenerative MedicineCell TherapyPancreatic CancerLentiviral TransductionMedicine	2008	56
Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma Alexei V. Salnikov, Ariane Groth, Anja Apel, Journal of Cellular and Molecular Medicine Tumor BiologyCancer ImmunosurveillancePancreatic CancerBivalent Anti-cd3 AntibodyMedicine	2009	43
Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study Claude Négrier, Johnny Mahlangu, Michaela Lehle, Blood	2021	12

Page 1